PharmaSynth AS
RegisteredNo tax debt
Revenue2025
896k €
Profit2025
236k €
EmployeesEMTA · Q3 2026
8
Equity2025
1.3M €
Main data
Contacts
Management board and persons on card
Aktsiaseltsi võib kõikide tehingute tegemisel esindada iga juhatuse liige.
- View profilePirkko Irene Penttilä-HiltunenBoard member
- Nasdaq CSD SEAktsiaraamatu pidaja
Other persons (off-card)
- Heli Väärtnõu-JärvShareholder · Owner account
- Jukka Veli HiltunenShareholder · Owner account
- Sillamatsi Medical OüShareholder · Owner account
- Nard Institute LtdShareholder · Owner account
- Heli Väärtnõu-JärvSupervisory board member
- Olavi LoogSupervisory board member
- Jaak JärvNõukogu esimees
- Maarika MägiAudiitorettevõtja
- Fiducia Audit OÜAudiitorettevõtja
- Heli Väärtnõu-JärvFounder
- Sillamatsi Medical OüFounder
- Oü EdusoftFounder
- Sari Anneli HalldinFounder
- Pirkko Irene Penttilä-HiltunenFounder
- Jukka Veli HiltunenFounder
- Jaak JärvFounder
- Christer HalldinFounder
Areas of activity
Põhifarmaatsiatoodete tootmine21101
Tax debt
The Estonian Tax and Customs Board publishes debts from EUR 100. The total includes deferred and disputed amounts. Disputed debt with suspended enforcement is not published. Only legal persons are published.No tax debt
Data as of 13.10.2026
Tax and Customs Board data
Labour taxes are the amounts actually paid during the quarter.- Revenue 2025 (annual report)896,270 €
- Turnover, last 12 months (EMTA, to 2026 Q3)693,368 €
- Employees 2025 (annual report, FTE)9
- Employees (EMTA, 2026 Q3)8
- Labour taxes, last 12 months (EMTA, to 2026 Q3)180,389 €
- State taxes, last 12 months (EMTA, to 2026 Q3)167,778 €
Data as of 10.10.2026
Financial indicators
Annual reports
Auditor of the last report: Fiducia Audit OÜ